Blood Test Identifies Risk of Nonalcoholic Fatty Liver Disease
Researchers have identified a noninvasive biomarker that can identify patients at risk of NAFLD complications using a simple blood test.
Read MorePosted by Chris Wolski | Jun 17, 2021 | Diabetes & Metabolic Diseases |
Researchers have identified a noninvasive biomarker that can identify patients at risk of NAFLD complications using a simple blood test.
Read MorePosted by Laurie Bonner | Mar 26, 2021 | Disease States |
Early detection, monitoring, and noninvasive diagnostic testing are essential to controlling this epidemic.
Read MorePosted by Melanie Hamilton-Basich | Feb 25, 2021 | Prenatal Testing |
The method uses a DNA biomarker to easily screen pregnant women for harmful prenatal environmental contaminants like air pollution linked to childhood illness and developmental disorders.
Read MorePosted by Melanie Hamilton-Basich | Feb 18, 2021 | Hematology & Serology, Research |
New research has shown that results of blood tests routinely performed by GPs everywhere contain a hidden fingerprint that can identify people silently developing potentially fatal liver cirrhosis.
Read MorePosted by Melanie Hamilton-Basich | Dec 7, 2020 | Research |
Results of standard laboratory tests performed on adult outpatients to provide an overall picture of their health are fairly consistent between those with obesity and their leaner counterparts, investigators report.
Read More